Open Access

Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds

  • Authors:
    • George Nicolae Daniel Ion
    • Octavian Tudorel Olaru
    • Georgiana Nitulescu
    • Iulia Ioana Olaru
    • Aristidis Tsatsakis
    • Tatiana I. Burykina
    • Demetrios A. Spandidos
    • George Mihai Nitulescu
  • View Affiliations

  • Published online on: June 5, 2020     https://doi.org/10.3892/or.2020.7636
  • Pages: 589-598
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

One of the most commonly discussed topics in the field of drug discovery is the continuous search for anticancer therapies, in which small‑molecule development plays an important role. Although a number of techniques have been established over the past decades, one of the main methods for drug discovery and development is still represented by rational, ligand‑based drug design. However, the success rate of this method could be higher if not affected by cognitive bias, which renders many potential druggable scaffolds and structures overlooked. The present study aimed to counter this bias by presenting an objective overview of the most important heterocyclic structures in the development of anti‑proliferative drugs. As such, the present study analyzed data for 91,438 compounds extracted from the Developmental Therapeutics Program (DTP) database provided by the National Cancer Institute. Growth inhibition data from these compounds tested on a panel of 60 cancer cell lines representing various tissue types (NCI‑60 panel) was statistically interpreted using 6 generated scores assessing activity, selectivity, growth inhibition efficacy and potency of different structural scaffolds, Bemis‑Murcko skeletons, chemical features and structures common among the analyzed compounds. Of the most commonly used rings, the most prominent anti‑proliferative effects were produced by quinoline, tetrahydropyran, benzimidazole and pyrazole, while overall, the optimal results were produced by complex ring structures that originate from natural compounds. These results highlight the impact of certain ring structures on the anti‑proliferative effects in drug design. In addition, considering that medicinal chemists usually focus their research on simpler scaffolds the majority of the time with no significant pay‑off, the present study indicates several unused complex scaffolds that could be exploited when designing anticancer therapies for optimal results in the fight against cancer.

Related Articles

Journal Cover

August-2020
Volume 44 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Ion, G.N., Olaru, O.T., Nitulescu, G., Olaru, I.I., Tsatsakis, A., Burykina, T.I. ... Nitulescu, G.M. (2020). Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds. Oncology Reports, 44, 589-598. https://doi.org/10.3892/or.2020.7636
MLA
Ion, G. N., Olaru, O. T., Nitulescu, G., Olaru, I. I., Tsatsakis, A., Burykina, T. I., Spandidos, D. A., Nitulescu, G. M."Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds". Oncology Reports 44.2 (2020): 589-598.
Chicago
Ion, G. N., Olaru, O. T., Nitulescu, G., Olaru, I. I., Tsatsakis, A., Burykina, T. I., Spandidos, D. A., Nitulescu, G. M."Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds". Oncology Reports 44, no. 2 (2020): 589-598. https://doi.org/10.3892/or.2020.7636